Combining atezolizumab to neoadjuvant chemotherapy does not improve pathologic complete response rates for TNBC patients

Breast cancer prevention in high-risk post-menopausal women

Accelerated partial breast irradiation versus whole breast irradiation in patients with early breast cancer

Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of triple-negative breast cancer

Preventative effects of anastrozole in post-menopausal women who are at high-risk for developing breast cancer

How effective is accelerated partial breast irradiation in patients with early breast cancer?

Predicting disease recurrence in patients with early triple-negative breast cancer using circulating tumour DNA

The emerging role of immunotherapy for the treatment of early and advanced breast cancer

APHINITY: Adding pertuzumab to trastuzumab plus chemotherapy in patients with operable HER2-positive early breast cancer

Breast cancer incidence in post-menopausal women: Long-term influence of oestrogen plus progestin versus oestrogen alone

Could trastuzumab deruxtecan become the new standard of care for pretreated HER2-positive breast cancer patients?

Addition of S-1 to post-operative endocrine therapy for patients with hormone receptor-positive HER2-negative breast cancer